Physician profile
Robert E Lane
NPI 1245312834
$2,409.21
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $882 · 2020: $465 · 2021: $370 · 2022: $13.34 · 2023: $631 · 2024: $47.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $481 · Entertainment: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $480.65 |
| Entertainment | $197.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,347.67 | 2019-2021 | |
| Zimvie INC. | $337.38 | 2022-2024 | |
| Nobel Biocare USA | $209.55 | 2019-2023 | Nobelactive |
| Keystone Dental INC. | $197.90 | 2023 | |
| Aerin Medical INC. | $104.00 | 2019 | |
| Salvin Dental Specialties, INC. | $42.85 | 2021 | |
| Peter Brasseler Holdings, LLC | $40.00 | 2019 | |
| 3m Company | $40.00 | 2023 | Scotchbond Universal Plus, 3m Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative |
| Kerr Corporation | $37.79 | 2023 | Fill/Obturation |
| Align Technology, INC. | $33.33 | 2021 | |
| Biohorizons Implant Systems INC. | $18.74 | 2023 | Biohorizons |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.